Apollo Hospitals in Aragonda has introduced a state-of-the-art ‘Uro Laser Technology Unit’ to improve the diagnosis and treatment of kidney stones and other nephrological conditions. The launch of this unit demonstrates the hospital’s dedication to providing high-quality healthcare services to rural communities. According to Dr. H.S. Shankar of Apollo Hospitals, the advanced laser technology employed in the unit enables minimally invasive and highly effective solutions for urological issues.

This cutting-edge technology allows for precise treatment with faster recovery times, significantly enhancing patient outcomes. The services offered by the Uro Laser Technology Unit will also be available under government-supported schemes, including Arogyasri and the Employees Health Scheme (EHS). This ensures that a broader segment of the population can access quality care, regardless of their financial means.

The introduction of this unit is a significant development for the region, as it provides patients with access to specialized urological care that was previously unavailable. The use of advanced laser technology is expected to reduce the need for invasive surgical procedures, resulting in less discomfort and scarring for patients. Furthermore, the faster recovery times enabled by this technology will allow patients to resume their normal activities more quickly, improving their overall quality of life.

The launch of the Uro Laser Technology Unit is part of Apollo Hospitals’ ongoing efforts to expand access to quality healthcare services in rural areas. By investing in advanced medical technology and expertise, the hospital aims to bridge the gap in healthcare services between urban and rural communities. The availability of these services under government-supported schemes is a significant step towards achieving this goal, as it ensures that quality healthcare is accessible to a wider segment of the population.

Overall, the introduction of the Uro Laser Technology Unit at Apollo Hospitals in Aragonda marks a significant milestone in the hospital’s mission to deliver world-class healthcare services to rural communities. With its advanced technology and commitment to accessibility, the unit is poised to make a positive impact on the lives of patients in the region.

Healthcare Scan Diagnostics (HSD), a state-of-the-art diagnostic center in Kolkata, has partnered with Apollo Hospitals, Chennai to bring world-class healthcare expertise to patients in West Bengal. As part of this collaboration, renowned doctors from Apollo Hospitals, including specialists, will visit HSD on April 19-20 to consult patients in person. Following this initial visit, Apollo specialists will conduct regular OPD sessions at the clinic, making expert healthcare services more accessible to patients in the region.

This partnership aims to enhance patient care in Kolkata by leveraging Apollo’s renowned expertise and setting new standards in diagnostics and treatment. Dr. Haseeb Hassan, consultant senior neurologist and director of Healthcare Scan Diagnostics, expressed pride in the collaboration, stating that it will bring expert healthcare services to patients in the region, making world-class healthcare more accessible to everyone.

The partnership will also save patients time and trouble by minimizing the distance they would otherwise have to travel to Chennai for expert consultations. HSD’s goal is to offer comprehensive health solutions to the people of Kolkata and surrounding areas, providing the best services close at hand. The collaboration is expected to redefine the healthcare experience in the region and provide patients with access to top-notch medical care without having to travel long distances.

A cardiologist, Dr. Bikash Rai Das, has been arrested by the Dispur Police in Guwahati, India, for allegedly sexually harassing the minor daughter of his friend. The victim’s mother lodged a complaint with the police, alleging that Dr. Das had committed the offense at his apartment in Christian Basti locality. The police registered a case against Dr. Das under sections 354 (assault or criminal force on a woman with intent to outrage her modesty) and 354 A (sexual harassment) of the Indian Penal Code.

Dr. Das has also been charged under Section 8 of the Protection of Children from Sexual Offences (POCSO) Act, which deals with the sexual assault of children. Despite being summoned to appear before the police, Dr. Das evaded arrest until he was finally caught on Sunday evening from Apollo Hospitals, where he worked. The police team that arrested him went in disguise as patients to avoid alerting Dr. Das.

Dr. Das is a prominent doctor in Guwahati, and his arrest has sent shockwaves in the medical community. The incident highlights the need for greater vigilance and accountability among public figures, particularly in professions that involve working with vulnerable populations such as children and women. The police have acknowledged the gravity of the offense and are working to ensure that Dr. Das is punished to the fullest extent of the law.

Here is a 400-word summary of the article:

The Indraprastha Apollo Hospitals hosted the Third Apollo Neuro Conclave 2025, a two-day conference on neurological care and treatment protocols, on April 12-13. The conclave brought together leading healthcare professionals from neurology, neurosurgery, neuro-intensivists, and researchers to discuss the latest advancements in neurological care. The conference aimed to provide a platform for the sharing of pioneering insights and transformative strategies in neurological treatment.

The conclave’s focus is on “Recent Advances in Treatment Protocols,” with speakers and panelists sharing their expertise and best practices in the field. Dr. Vinit Suri, Senior Consultant in Neurology at Indraprastha Apollo Hospitals, said that the conclave highlights the importance of collaboration and research in improving patient outcomes.

Dr. Sudheer Kumar Tyagi, Senior Consultant in Neurosurgery at Indraprastha Apollo Hospitals, emphasized the unique aspect of the conclave, which is the unity and participation of various neuro-related disciplines. He noted that the event showcases the Apollo Group’s strength in integrating talent, technology, and teamwork, and its ability to inspire the next generation of healthcare professionals.

The conclave is expected to have a significant impact on neurological care in India, with experts presenting cutting-edge treatment protocols that have the potential to revolutionize the field. The event is designed to be an enriching experience for those in attendance, offering a platform for discussion and knowledge-sharing among leading minds in the field.

The collaboration among neurologists, neurosurgeons, and other healthcare professionals is expected to lead to improved patient outcomes and better treatment options. The conclave’s focus on recent advances in treatment protocols is expected to help healthcare professionals stay up-to-date on the latest developments in neurological care.

The event also serves as a testament to the commitment of the Apollo Hospitals Group to advancing neurological care in India. With its extensive research in neurosciences, the Apollo Group is well-positioned to make a significant impact in the field of neurological care. The Third Apollo Neuro Conclave 2025 is an exciting development in the Indian healthcare landscape, with the potential to benefit patients and transform the future of neurological treatment.

Here is a summary of the content in 400 words:

Apollo Cancer Centres (ACC) has launched a comprehensive screening program called ColFit to detect and prevent colorectal cancer (CRC) in India. The program aims to improve survival rates, reduce treatment costs, and address the concerning trend of late-stage diagnoses. Despite being preventable and treatable, a significant proportion of CRC cases in India are identified at advanced stages, resulting in poor outcomes and higher healthcare burdens.

ColFit focuses on expanding CRC screening among both older and younger populations, emphasizing the importance of early detection. The program uses the Faecal Immunochemical Test (FIT), a non-invasive and highly accurate screening tool that identifies hidden blood in stool, a potential early indicator of CRC. The screening process involves registration, risk stratification, analysis, and diagnosis, as well as follow-up and counseling.

Apollo Cancer Centres’ clinicians stress the need for proactive screening, citing lifestyle factors such as poor diet, sedentary habits, and obesity as major contributors to rising CRC cases. They emphasize the importance of high-fiber diets, regular exercise, and proactive screenings in preventing CRC. The organization also highlights the urgent need to improve survival rates in India, where the five-year survival rate for CRC is less than 40%, one of the lowest globally.

ColFit aims to empower individuals to take control of their health by offering a seamless screening-to-treatment pathway. The program’s multidisciplinary approach involves oncologists, gastroenterologists, and other specialists working together to provide personalized treatment plans. Apollo Cancer Centres urges individuals, especially those with a family history of CRC or persistent symptoms, to prioritize regular screenings.

The organization’s mission is to educate and raise awareness about the preventable nature of colorectal cancer, offer cutting-edge treatments, and promote early detection and better outcomes. By providing a comprehensive approach to CRC screening and treatment, Apollo Cancer Centres seeks to reduce the burden of CRC in India.

The Apollo Hospitals Group has released its fifth edition of the Health of the Nation (HoN) 2025 report, highlighting a significant increase in preventive health checks, with over 2.5 million individuals screened in 2024, a 150% increase from 2019. The report emphasizes the importance of proactive engagement with preventive healthcare and early detection of chronic conditions.

Key findings from the report include:

* 26% of individuals were found to be hypertensive without any symptoms.
* 23% of individuals were diagnosed with diabetes without showing any symptoms.
* 65% of individuals screened for fatty liver disease had the condition, with 85% being non-alcoholic.
* 46% of asymptomatic individuals showed signs of early atherosclerosis.

The report also highlights the need for early personalized interventions and lifestyle-based care models for three urgent health challenges: fatty liver disease, post-menopausal health decline, and childhood obesity.

Apollo Hospitals’ Chairman, Dr. Prathap Reddy, emphasizes the importance of placing health at the heart of every household and integrating preventive care into every educational curriculum, corporate benefits, and family routines.

The report’s findings underscore the need for a shift from treating illness to preserving health and the importance of preventive healthcare in ensuring a resilient, healthier India for generations to come.

I apologize, but there seems to be no content provided for me to summarize. It appears to be a link or a title, but without the actual content, I’m unable to summarize it for you.

However, I can provide some general information on izitofu (mRNA) and its applications in the context of Apollo Hospitals, an Indian hospital chain.

mRNA (Messenger RNA) is a type of RNA that plays a crucial role in protein synthesis. It is a genetic material that carries genetic information from DNA to the ribosomes, which then use this information to build proteins. Recent advances in gene editing technologies, such as CRISPR-Cas9, have led to increased interest in mRNA therapies for various diseases.

Apollo Hospitals, founded in 1983, is one of the largest and most renowned hospital chains in India. With a strong focus on innovation, Apollo Hospitals has been at the forefront of embracing cutting-edge technologies, including genomics and gene editing.

In the context of izitofu (mRNA), Apollo Hospitals has been exploring its potential applications in various disease areas, including oncology, neurology, and rare genetic disorders. The hospital chain has established partnerships with leading mRNA therapy developers and research institutions to advance the development of mRNA-based treatments.

Apollo Hospitals has also established a Center for Genomic Medicine and Gene Therapy, which focuses on the diagnosis and treatment of genetic disorders using cutting-edge technologies like CRISPR-Cas9. The center aims to leverage the potential of mRNA and gene editing to develop innovative therapies for a range of diseases.

In summary, while there is no specific content to summarize, Apollo Hospitals is exploring the potential of mRNA (izitofu) as a therapeutic approach for various diseases, and has established partnerships and research collaborations to advance this field.

However, I don’t see any content provided. It seems like the inshorts link was truncated and only a single line was visible.

Please provide the complete content, and I’ll be happy to summarize it for you within the 400-word limit.

Indraprastha Apollo Hospitals, a leading healthcare provider, has partnered with Aamina Hospital in Srinagar to bring world-class medical services to the region. As part of this collaboration, a team of 20 specialized doctors from various fields will provide outpatient department (OPD) consultations at Aamina Hospital every month. These doctors will offer invasive and non-invasive procedures, ensuring that patients in Srinagar have access to top-notch healthcare without having to travel long distances.

The doctors who will be visiting Aamina Hospital include specialists in cosmetic, plastic, and reconstructive surgery, surgical oncology and robotics, and other fields. They will provide comprehensive medical consultations and the latest treatment options, including advanced cancer treatments like robotic surgery, immunotherapy, and targeted therapy.

This partnership aims to bridge the healthcare gap in the region and improve patient outcomes. Dr. Shahin Nooreyezdan, a senior consultant at Indraprastha Apollo Hospitals, emphasized the importance of this initiative, stating that it will ensure that quality healthcare reaches everyone in need.

Aamina Hospital’s Managing Director, Dr. Mushtaq Ahmad Purzgar, expressed enthusiasm about the collaboration, saying that it will greatly benefit the people of Srinagar and improve the overall health infrastructure in the region. The partnership reaffirms Apollo Hospitals’ commitment to expanding its reach and making specialized healthcare more accessible.

With this collaboration, residents of Srinagar can expect to receive world-class medical care closer to home, without having to travel long distances to access specialized treatments. The partnership is a significant milestone in the growth of healthcare services in the region and is expected to improve patient outcomes and enhance accessibility to quality healthcare for all.

Indraprastha Apollo Hospitals, a renowned medical institution, has announced a strategic partnership with Aamina Hospital and Nursing Home in Srinagar to bring world-class healthcare services to the region. As part of this collaboration, a team of 20 experts from Apollo will conduct monthly outpatient consultations at Aamina Hospital, offering advanced treatment options to patients in the area.

The partnership aims to bridge the healthcare gap and bring expert medical care closer to the people of Srinagar. The Apollo team will provide comprehensive consultations, invasive and non-invasive procedures, and advanced treatment options, ensuring that patients do not have to travel outside the region for specialized care.

Dr. Shahin Nooreyezdan, Senior Consultant for Cosmetic, Plastic, and Reconstructive Surgery at Indraprastha Apollo Hospitals, highlighted the importance of the initiative, stating that it is a significant step in improving accessibility and enhancing patient outcomes. Dr. Sameer Kaul, Senior Consultant for Surgical Oncology and Robotics at Indraprastha Apollo Hospitals, mentioned that the goal is to offer patients the latest medical treatments and surgical interventions without requiring them to travel long distances.

Dr. Mushtaq Ahmad Purzgar, Managing Director of Aamina Hospital Srinagar, expressed confidence that this partnership will enhance the region’s health infrastructure and raise the standard of patient care. The collaboration underscores Apollo Hospitals’ commitment to expanding access to specialized healthcare services, with Apollo’s renowned doctors now available at Aamina Hospital, offering world-class medical care to patients in Srinagar.

Here is a summary of the content in 400 words:

Apollo Hospitals, a leading healthcare provider, has launched a Genomics Institute in Karnataka to advance the field of precision medicine. The institute is dedicated to understanding the genetic basis of diseases and developing targeted treatments. The move marks a significant step forward in the use of genomics in patient care, particularly in the fields of oncology, cardiology, and neurology.

The Genomics Institute will be led by Dr. Reddy, a renowned geneticist, and will work in collaboration with Apollo Hospitals’ existing teams, including the Department of Genetic Medicine, to provide comprehensive genomic services to patients. The institute will offer cutting-edge diagnostic and therapeutic solutions, making use of cutting-edge technologies such as polymerase chain reaction (PCR), Next-generation Sequencing (NGS), and Massively Parallel Sequencing (MPS).

The institute’s research focus areas include:

1. Personalized Medicine: Developing tailored treatments based on individual patient genotypes to improve treatment outcomes.
2. Precision Diagnostics: Utilizing genomic data to diagnose diseases more accurately and quickly, reducing the need for invasive procedures.
3. Predictive Medicine: Identifying high-risk patients for specific diseases, enabling targeted interventions and prevention strategies.

The Genomics Institute in Karnataka will also offer training and education programs for healthcare professionals, enabling them to incorporate genomics into their daily practice. Additionally, the institute will serve as a hub for collaborative research, fostering partnerships with academia, industry, and other healthcare institutions.

With the launch of this Genomics Institute, Apollo Hospitals underlines its commitment to innovation, prioritizing patient-centric care and evidence-based medicine. By harnessing the power of genomics, the hospital hopes to improve patient outcomes, enhancing the quality of care and life for those patients seeking medical attention.

The Supreme Court of India has taken a stern stance on the alleged non-compliance of a lease agreement by Indraprastha Apollo Hospital in New Delhi. The hospital, run by Indraprastha Medical Corporation Limited (IMCL), was to provide free medical and other facilities to one-third of its indoor poor patients and 40% of its outdoor patients without discrimination, as per the lease agreement. However, the hospital has instead turned into a commercial venture, making it difficult for poor patients to afford treatment.

The Supreme Court bench, comprising Justices Surya Kant and N Kotiswar Singh, has threatened to hand over the hospital to the All India Institute of Medical Sciences (AIIMS) if it does not comply with the lease agreement. The bench has observed that the hospital, which was constructed on a 15-acre land in a posh area of Delhi, was to be run on a “no profit and no loss” formula, but has instead become a pure commercial venture.

The hospital’s counsel has argued that the Delhi government, which has a 26% shareholding in the hospital, is equally benefiting from its earnings. However, the bench has expressed its concern, saying that if the Delhi government is earning profit from the hospital instead of taking care of poor patients, it is an unfortunate thing.

The Supreme Court has also sought information on the lease agreement, asking the Centre and the Delhi government to find out whether the agreement has been renewed or not. It has also asked the hospital administration to provide records of the number of poor patients who have received free treatment in the past five years and sought its cooperation with an inspection team.

The court has posted the matter for hearing after four weeks, giving the hospital administration the liberty to file its affidavit, if any. The case is a significant one, as it highlights the need for hospital administrators to prioritize the needs of poor patients and to ensure that they receive timely and necessary medical care.

Here is a 400-word summary of the content:

Lipedema is a condition characterized by the accumulation of fat cells in the legs and buttocks, often causing discomfort and mobility issues. While the exact cause of lipedema is unknown, it is believed to be related to hormonal imbalances and genetics. The condition is more common in women, with an estimated 11% of women affected.

The symptoms of lipedema include a range of physical and emotional problems, including chronic fatigue, depression, and anxiety. Weight gain is also a common feature, as the excess fat cells can lead to weight fluctuations.

There are various treatment options available for lipedema, including decongestive therapy, compression therapy, and invasive therapies such as liposuction. Decongestive therapy involves using manual lymphatic drainage techniques to remove excess fluid from the affected areas, while compression therapy involves using compression garments to help reduce swelling.

Invasive therapies, such as liposuction, are also used to remove excess fat cells. However, these procedures are often not effective on their own and may require a combination of other treatments.

In addition to traditional medical treatments, there are also various alternative therapies that can help manage lipedema symptoms. These include a focus on maintaining a healthy lifestyle, including regular exercise and a balanced diet, as well as stress reduction techniques and self-care practices.

Ultimately, the treatment of lipedema requires a holistic approach that addresses both the physical and emotional aspects of the condition. By combining traditional medical treatments with alternative therapies and lifestyle changes, individuals with lipedema can work to manage their symptoms and improve their overall quality of life.

Apollo Speciality Hospitals has achieved a major surgical feat by successfully performing two complex procedures on patients with extensive skull base injuries and a rare growth hormone-secreting tumor, respectively. The team, led by Dr. P. Meena Priyadharshini, worked together to perform the surgeries with precision and expertise.

The first patient, who had suffered traumatic skull base injuries, was treated with a pioneering approach that combined transcranial and trans-nasal endoscopic skull base repair. This innovative method ensured a seamless repair of the skull base at five sites, a milestone in neuro and ENT surgery. The patient made a remarkable recovery, regaining full mobility and being discharged without any residual complications within two weeks.

The second patient, a 50-year-old woman, had been experiencing progressive changes in facial structure, hands, and voice due to a rare growth hormone-secreting tumor in the pituitary gland. The team, including Dr. R. M. Manikandan and Dr. Shankar Vangipuram, successfully performed an endoscopic excision of the tumor extending to the suprasellar region. The patient’s diabetes, which had been exacerbated by the tumor, showed significant improvement following treatment. The patient’s blood parameters, including insulin-like growth hormone, returned to normal levels within nine months.

Dr. Meena Priyadharshini emphasized the importance of teamwork and multidisciplinary collaboration in achieving these complex surgeries. She noted that the hospital’s commitment to providing world-class healthcare through expertise and advanced technology helped to deliver successful outcomes.

The hospital’s COO, P. Neelakannan, highlighted the significance of these groundbreaking surgeries in their mission to provide top-notch healthcare. With cutting-edge technology and expert professionals, Apollo Speciality Hospitals is dedicated to delivering the best possible care to its patients.

On March 26, 2025, the Apollo Cancer Centre in Hyderabad launched “ColFit”, a comprehensive screening program designed to detect and prevent colorectal cancer (CRC) at an early stage. The initiative aims to improve survival rates, reduce treatment costs, and address the trend of late-stage diagnoses, which lead to poor outcomes and increased healthcare burdens. The ColFit program uses the faecal immunochemical test (FIT), a non-invasive and highly accurate screening tool that identifies hidden blood in stool, a potential early indicator of CRC.

The FIT test is a simple and painless process that involves a small stool sample, which can help detect CRC early, even before symptoms appear. Early detection of CRC can significantly improve treatment outcomes, reduce healthcare costs, and save lives.

The launch of ColFit was attended by senior doctors, including Dr. Ajesh Raj Saksena, GI Surgical Oncologist, and Dr. Raghu DK, Medical Gastroenterologist from Apollo Hospitals. V Tejesvi, CEO of the Telangana region of Apollo Hospitals, was also present at the launch.

ColFit is a significant step towards reducing the incidence of CRC and improving healthcare in the region. It demonstrates Apollo Hospitals’ commitment to providing comprehensive and innovative solutions to address the growing burden of cancer. With ColFit, early detection and prevention of CRC will become more accessible, and people can take proactive steps to protect their health and well-being.

The Supreme Court of India has ordered an inspection of Apollo Hospital, a 600-bed multi-specialty hospital in New Delhi, to investigate whether it has been fulfilling its obligations to provide free treatment and hospital beds to poor patients, as stipulated in its lease deed. The hospital was established in 1994 on a 15-acre land parcel given by the Delhi government at a symbolic lease amount of ₹1 per month. The lease deed required the hospital to reserve at least one-third of the beds for free diagnostic facilities and provide free treatment to 40% of out-patient department (OPD) patients. However, the hospital has been accused of not adhering to these obligations. The court has directed the Centre and the Delhi government to constitute a joint inspection team to submit a report on the hospital’s compliance with the lease deed in four weeks. The court has also asked the hospital to provide full assistance to the inspecting team and produce all relevant records. The hospital has not commented on the matter. The court’s order is in response to an appeal filed by Indraprastha Medical Corporation Limited, which runs the hospital, challenging a 2009 order of the Delhi High Court in a public interest litigation alleging that the hospital was not providing medical facilities to the poor. The court has also directed the Delhi government and the Union Ministry of Health and Family Welfare to file an affidavit explaining whether the lease deed has been renewed and what steps have been taken to restore the government land if it has not been renewed.

Apollo Hospitals has launched the Apollo Joint Preservation Program, a revolutionary initiative aimed at providing comprehensive, patient-centric joint care in India. The program focuses on early intervention, personalized treatment, and proactive approach to joint health, with the goal of preserving mobility and confidence. The program is designed to alleviate joint pain and potentially delay or avoid invasive procedures.

The program offers a range of innovative treatments, including platelet-rich plasma (PRP) therapy, ozone therapy, and orthobiologics, which empower patients to take control of their joint health. Patients will also receive comprehensive support services, including physiotherapy, rehabilitation, nutritional advice, and alternative therapies like yoga.

The program is tailored to the needs of patients suffering from joint pain, arthritis, inflammatory conditions, and ligament injuries. By emphasizing active and healthy lifestyle habits, the program aims to address discomfort and potentially prevent the need for surgical interventions.

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, congratulated the team on the launch, stating that the program is designed to benefit individuals of all ages who may not be aware of treatment options for joint pain or degeneration. The program’s three key aspects are tailored advice, treatment (medical and surgical), and therapies (rehabilitation, nutrition, and alternative therapies).

Senior orthopaedic surgeons from Apollo Hospitals, including Dr. A. Navaladi Shankar, Dr. Kornad P. Kosygan, and Dr. Arun Kannan, also spoke at the launch, highlighting the program’s innovative therapies and comprehensive approach. They emphasized the importance of empowering patients to take control of their joint health and maintain an active lifestyle.

The program aims to provide a range of treatment options, including non-invasive treatments, which can potentially delay or avoid major joint health issues. Patients will have access to a wide array of comprehensive treatment options, including traditional and alternative therapies, to help them preserve their mobility and quality of life. With this initiative, Apollo Hospitals is committed to enhancing the quality of life for all, promoting a more active and fulfilling lifestyle.

Apollo Hospitals, a leading healthcare provider, has launched a new program called “Seniors First” at its Bannerghatta hospital in Bengaluru, exclusively designed for senior citizens. The program aims to provide a comprehensive and seamless healthcare experience for seniors, breaking down traditional barriers in care delivery. The initiative brings together multidisciplinary teams, including doctors, nurses, physiotherapists, and social workers, to provide personalized health plans, continuous health monitoring, and rehabilitation support.

The program offers a range of services, including personalized wellness plans, proactive health monitoring, rehabilitation support, emotional and caregiver assistance, diet guidance, and 24×7 medical and homecare services. The hospital claims that the program is designed to provide a connected and compassionate healthcare ecosystem, focusing on the unique needs of seniors.

Karnataka Health Minister Dinesh Gundu Rao praised the initiative, stating that it is a vital step towards ensuring that the elderly receive healthcare that is not only advanced but also compassionate and accessible. The program is designed to cater to the needs of seniors, providing them with a range of services to improve their overall health and well-being.

By launching “Seniors First,” Apollo Hospitals is once again setting a new standard for healthcare in India, providing a benchmark for other healthcare providers to follow. The program is a testament to the hospital’s commitment to providing high-quality care to its patients, particularly the elderly, and its mission to create a healthier and more compassionate society.

Apollo Hospitals has launched a pioneering initiative called “Seniors First”, aimed at providing comprehensive healthcare services for senior citizens. This integrated geriatric care program focuses on preventive wellness, structured recovery after major medical procedures, and continuous health monitoring. The program brings together multi-specialist teams, hospital-to-home transitions, and personalized health plans to create a connected and compassionate care ecosystem for the elderly.

The initiative aims to bridge the existing gaps in geriatric care, offering support tailored to the specific health challenges faced by older adults. The program provides specialized services, including personalized wellness plans, proactive health monitoring, rehabilitation support, emotional and caregiver assistance, dietary guidance, and a dedicated helpline and concierge services.

The Health Minister, Dinesh Gundu Rao, inaugurated the initiative, emphasizing the importance of making advanced and accessible healthcare available to senior citizens. He noted that “This is a vital step in ensuring that our elderly receive not only the best medical care but also the dignity and support they deserve.”

According to Dr. Madhu Sasidhar, President and CEO of Apollo Hospitals, there is a pressing need for specialized geriatric care in India, where over 140 million senior citizens often struggle with multiple chronic conditions, frequent hospitalizations, and complex medication regimens. Seniors First is designed to address these challenges by offering a sustainable and personalized model of care.

Overall, Seniors First aims to provide a comprehensive and holistic approach to healthcare for senior citizens, focusing on their unique needs and ensuring they receive the support and dignity they deserve.

Here is a 400-word summary of the content:

Stroke is a significant public health concern in India, ranking fourth in terms of mortality rate and fifth in terms of disability. To address this issue, two hospitals in India, Apollo Hospital in Hyderabad and Aster Hospital in Calicut, have been certified as Comprehensive Stroke Centers by the American Stroke Association (ASA), a division of the American Heart Association. This certification recognizes hospitals that have the necessary infrastructure, equipment, and trained staff to quickly diagnose and treat complex stroke cases.

The ASA launched its certification program in India last year, focusing on promoting high-quality care for stroke patients. The certification process involves a rigorous evaluation of the hospital’s infrastructure, equipment, and staff to ensure they meet specific standards for stroke care. There are two certification classifications: Comprehensive Stroke Centers and Primary Stroke Centers. Comprehensive Stroke Centers must meet advanced standards, including 24/7 availability of specialized treatments, participation in research, and staff education and competencies for complex stroke care.

Primary Stroke Centers, on the other hand, are required to demonstrate the ability to care for acute ischemic stroke patients, transfer patients to Comprehensive Stroke Centers, and meet educational requirements for all disciplines caring for stroke patients. The ASA surveyors assess hospitals to ensure they meet or exceed the required standards.

The ASA is also piloting a Comprehensive Chest Pain certification, which is part of its efforts to improve heart disease and stroke care globally. The certifications are designed to encourage hospitals to establish, improve, and support high-quality care for these conditions. With this initiative, the ASA is working towards reducing the impact of heart disease and stroke and enhancing patient outcomes. As Dr. D.P. Suresh, a volunteer member of the American Heart Association’s International Committee, emphasized, “It is up to us to create a better world for everyone.”

Apollo 24|7, a healthcare company, has seen significant growth in its online business, with its 19-minute delivery service contributing to nearly 30% of daily orders. The service, which was first launched in Delhi and Noida in November 2023, has since expanded to six major cities and plans to scale to 20 cities by the end of 2025. The company expects its daily online order volume to rise to 60,000 by the end of the year, with the proportion of 19-minute deliveries remaining steady at 28-30%.

Apollo’s rapid delivery service is made possible through a combination of large-format stores and dark stores, with the company operating around 12-14 large stores and 10-12 dark stores. The service uses an in-house team for 19-minute deliveries, while other orders are fulfilled through logistics partners like Shadowfax.

Apollo’s CEO, Madhivanan Balakrishnan, believes that the company’s extensive product range and prescription validation model give it an edge in the market. The company requires customers to either upload a doctor’s prescription or schedule a verification call for prescription drugs, which helps to ensure that only valid prescriptions are fulfilled. This model is necessary for expanding beyond over-the-counter medications, and the company is prepared to adapt to the growing competition in the market.

While there may be challenges in implementing this model, Balakrishnan notes that the 19-minute delivery service has not posed a significant challenge for the company so far. With its continued focus on innovation and customer satisfaction, Apollo 24|7 is well-positioned to maintain its position in the market.

Apollo Hospital in Hyderabad has launched a new program focused on joint preservation as an alternative to immediate surgery. The program aims to provide early intervention and personalized treatment to help individuals maintain their mobility and confidence. The “3 Ts” approach, which includes tailored advice, treatment (both medical and surgical), and therapies (including rehabilitation, nutrition, and alternative treatments), is designed to treat patients with joint pain, arthritis, inflammatory conditions, and ligament injuries. The program also offers advanced arthroscopic techniques and state-of-the-art treatments such as platelet-rich plasma (PRP) therapy and stem cell applications.

The program provides comprehensive support services, including physiotherapy, rehabilitation, and nutritional counseling, and is available to patients of all ages who are not aware of the available treatment options for joint pain or degeneration. The program is designed to benefit individuals who have been advised treatment for their affected joints elsewhere, as well as those seeking their first consultation for joint pain.

The program’s objective is to provide a personalized recovery plan for each patient, which will be available across Apollo’s network of 73 hospitals nationwide. According to Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, “This first-of-its-kind program offers an integrated pathway combining regenerative therapies with rehabilitation and nutritional support, providing each patient with a personalized recovery plan.”

Summary:

The article discusses the implementation of Duk Game da Bambancin (DGB) by Apollo Hospitals in the wake of the COVID-19 pandemic. DGB is an innovative platform that utilizes digital technology to connect people with the healthcare system, ensuring efficient and effective management of patients and resources. Introduced by Apollo Hospitals, a leading healthcare provider in India, DGB has been instrumental in ensuring continuity of care during the pandemic.

Key features of DGB include:

1. Remote consultations: Patients can now consult with healthcare professionals remotely, reducing the need for in-person visits to hospitals. This has helped to reduce crowding and transmission risks.
2. Telemedicine services: Apollo Hospitals has leveraged digital communication platforms to enable online consultations, medication management, and case monitoring. This has improved access to healthcare services, particularly for those in remote areas or with mobility issues.
3. Digital health records: DGB ensures seamless tracking and management of patient records, enabling healthcare professionals to access vital information quickly and securely.
4. Real-time monitoring: Apollo Hospitals’ team can now monitor patient conditions in real-time, enabling early detection and response to potential complications.
5. Streamlined operations: DGB has enabled hospitals to optimize patient flow, reduce waiting times, and minimize the use of physical resources, thereby reducing costs.

The implementation of DGB by Apollo Hospitals has several benefits:

1. Enhanced patient experience: Patients can now access healthcare services from the comfort of their own homes, reducing anxiety and stress associated with hospital visits.
2. Improved care coordination: Healthcare professionals can now collaborate more effectively, ensuring continuity of care and reducing gaps in treatment.
3. Reduced healthcare expenditure: By reducing the need for in-person visits and streamlining operations, Apollo Hospitals can allocate resources more efficiently, leading to cost savings.
4. Increased access to care: DGB has enabled Apollo Hospitals to reach a broader patient base, particularly those in rural areas or with mobility issues, improving access to healthcare services.

In conclusion, the implementation of Duk Game da Bambancin (DGB) by Apollo Hospitals has revolutionized the way healthcare is delivered during the COVID-19 pandemic. The innovative platform has enabled remote consultations, telemedicine services, and real-time monitoring, improving patient experience, care coordination, and resource allocation. As the world continues to navigate the pandemic, DGB serves as a model for other healthcare providers to follow, ensuring continuity of care and improving healthcare outcomes.

Apollo Hospitals, a leading healthcare provider in India, is increasing its investment in artificial intelligence (AI) to improve operational efficiency and reduce administrative tasks for healthcare professionals. The hospital chain, which operates over 10,000 beds, has been allocating 3.5% of its digital budget to AI in the past two years and plans to increase this investment to free up more time for doctors and nurses.

Apollo’s goal is to use AI to automate tasks such as medical documentation, diagnostic support, and patient records management, allowing healthcare professionals to focus on more critical tasks. The hospital is developing AI-powered tools to analyze electronic medical records, provide diagnostic recommendations, and assist with test ordering and treatment plans. Additionally, Apollo is working on an AI-powered system to help clinicians select appropriate antibiotics.

The company plans to expand its bed capacity by one-third in the next four years, with a portion of the revenue from this expansion going towards further AI development. However, Apollo faces challenges such as high implementation costs, inconsistent data formats, and limited electronic medical records, which can slow AI adoption in the healthcare sector. Despite these challenges, healthcare providers believe that AI can improve efficiency and patient care, with investments expected to grow in the coming years.

Overall, Apollo’s increased investment in AI is a significant step towards improving healthcare operations and enhancing the patient experience. As the company looks to expand its bed capacity and AI capabilities, it will be interesting to see how it overcomes the challenges and maximizes the benefits of AI in the healthcare sector.

Apollo Hospitals has launched its “Joint Preservation Programme,” a comprehensive treatment plan designed to alleviate joint pain, arthritis, and inflammatory conditions, as well as ligament injuries. The programme is tailored to meet the unique needs of patients and is available at all Apollo Hospitals in India.

The programme aims to provide early intervention, personalized treatment, and rehabilitation to help individuals maintain their mobility and confidence. It focuses on the “3 T’s”: tailored advice, treatment (both medical and surgical), and therapies, including rehabilitation, nutrition, and alternative therapies.

Through this programme, patients will have access to a wide range of treatment options, including medical and surgical procedures, as well as alternative therapies like physical therapy, nutrition counseling, and complementary therapies. The programme is designed to help patients avoid invasive procedures and alleviate joint discomfort as quickly as possible.

The launch of the programme was marked by a press release from Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, who highlighted the importance of the programme in providing comprehensive care to patients. The programme is expected to benefit patients who have been previously advised to undergo treatment for their joint issues, as well as those seeking their first consultation for joint pain.

Several orthopedic specialists, including Dr. Brett Fritsch, Dr. KJ Reddy, and others, were present at the launch event, emphasizing the importance of prompt and effective treatment options for joint issues. With the launch of the Joint Preservation Programme, Apollo Hospitals aims to set a new standard in joint care, providing patients with a comprehensive and personalized approach to addressing their joint health concerns.

Renowned music composer AR Rahman was discharged from Chennai’s Apollo Hospital after receiving treatment for health issues. According to a statement released by the hospital management, Rahman visited the hospital on March 16 with dehydration symptoms and underwent a routine check-up, following which he was discharged. This announcement put to rest rumors that had been circulating throughout the morning, indicating that the Oscar-winning musician had been admitted to the hospital due to chest discomfort after returning from London, where he attended an event.

Actually, Rahman had recently returned to Chennai and experienced neck and stomach pain, which he initially attributed to acidity and gastric issues. He self-medicated with antacids and anti-gas syrup at home, but when the discomfort persisted, he was taken to the hospital.

Rahman’s sister, Fathima, confirmed that her brother was hospitalized due to dehydration caused by his constant travel and lack of rest. He received drips and is now fine. Additionally, his son Ameen posted on his Instagram account that his father is doing well. The health scare appears to be attributed to exhaustion and dehydration, not any serious underlying condition. With his release from the hospital, AR Rahman is expected to resume his musical endeavors and continue to delight his fans worldwide with his melodious soundtracks.

In an innovative effort to raise awareness on the importance of sleep health, Apollo Specialty Hospital, Vanagaram organized India’s first sleep chain at the Vanagaram junction to commemorate World Sleep Day 2025. The event aimed to highlight the significance of sleep, with over 60% of Indians suffering from poor sleep quality, and its link to various health issues like heart disease, diabetes, and mental health disorders. The sleep chain, featuring doctors and nurses holding pillows with messages on the importance of sleep, is a powerful reminder that sleep is a biological necessity, not a luxury.

The initiative emphasizes the need for small but crucial lifestyle changes, such as consistent sleep schedules, reduced screen time, and seeking medical help, to address sleep disorders. Dr. Karthik Madesh, HOD and Clinic Head of the Institute of Sleep Health at Apollo Speciality Hospitals-Vanagaram, stressed that good sleep is critical to good health, citing its equal importance along with diet and exercise.

Dr. Prabhash Prabhakaran, HOD and Senior Consultant, Neurology, added that sleep is often underestimated as a fundamental pillar of health, and initiatives like the sleep chain play a vital role in highlighting its importance. He praised Apollo Specialty Hospital for its commitment to promoting sleep wellness and leading efforts to address sleep-related challenges.

The event was attended by experts, including Dr. Mohanakrishnan, Consultant, Pulmonology, and Dr. Rahul Raghav Menon, CEO and DMS, Apollo Speciality Hospitals, Vanagaram. Apollo Specialty Hospital is also home to the Institute of Sleep Health, a center dedicated to diagnosing and treating sleep disorders, including sleep apnea, insomnia, and narcolepsy. The hospital’s team of specialists, using advanced sleep studies and diagnostic tools, provides accurate assessments and tailored treatment plans to help patients achieve restorative sleep, leading to improved overall well-being and quality of life.

According to recent data from Apollo Bangalore, men are three times more likely to receive kidney transplants compared to women. The Apollo Healthcare data analysis reveals significant disparities in kidney transplant rates between males and females.

The study found that 43.2% of all kidney transplants were performed on male recipients, while 14.5% were for female recipients. This disparity is attributed to various factors, including the higher incidence of chronic kidney disease (CKD) and faster progression of kidney damage in men.

Researchers also discovered that men are more likely to suffer from hypertension, a significant risk factor for CKD. Moreover, men are more likely to experience kidney damage caused by factors such as diabetes, obstructive sleep apnea, and certain medications.

The Apollo Bangalore data analysis also showed that the frequency of kidney transplants in both men and women varied significantly with age. The majority of kidney transplants (45.1%) were performed on individuals between the ages of 45 and 64 years. In contrast, only 24.5% of transplants were performed on individuals under the age of 45.

In terms of the hashtags, it seems like the profile of the recipient of kidney transplants is changing dramatically: #Apollobangalore #Kidney transplantation #Transplantrates #TRENDS

The Apollo Symposium on Pulmonary Interventions and Respiratory Excellence (ASPIRE) 2025 was recently held in Hyderabad, Telangana. The event brought together pulmonologists, rheumatologists, and healthcare professionals to discuss recent advancements in the diagnosis and management of Interstitial Lung Disease (ILD), a condition that affects an estimated 4-8 lakh people in India.

The symposium focused on bronchoscopic techniques, high-resolution imaging, and biomarker-driven diagnostics that are improving ILD detection. Experts also examined new pharmacological treatments, including antifibrotic drugs and biologics, which are shaping ILD management in India.

The event featured participation from leading international and national medical professionals, including experts from the University of Washington Medical Center, University of Cincinnati, and Baylor College of Medicine, among others.

The Apollo Hospitals Pulmonology Department organized the event, led by Dr. Sowmya Parimi, Dr. Vijay Kumar Chennamsetty, and other committee members. The symposium covered topics such as AI-driven diagnostics, cryobiopsy for tissue acquisition, pulmonary rehabilitation, lung transplantation, and remote monitoring for ILD patients.

Apollo Hospitals’ CEO, Mr. V Tejesvi Rao, highlighted the importance of integrating cutting-edge technology in respiratory care, while Dr. Ravindra Babu, Director Medical Services, emphasized the need for a collaborative approach to diagnose and manage ILD. The event served as a crucial knowledge-sharing platform, fostering collaboration among specialists to advance data-driven ILD diagnosis and targeted therapeutic interventions.

ASPIRE 2025 marked an important step in improving ILD management across India, with Apollo Hospitals committed to pioneering evidence-based and technology-driven respiratory care. The event reflects the hospital’s dedication to providing the best available care to patients and contributing to the advancement of medical knowledge.

The Apollo Hospitals group hosted the ASPIRE 2025 symposium, a conference focused on pulmonary interventions and respiratory excellence, in Hyderabad. The event aimed to address Interstitial Lung Disease (ILD), a condition that affects an estimated 4-8 lakh people in India, with rising prevalence due to increasing air pollution, occupational hazards, and delayed diagnosis.

The symposium brought together pulmonologists, rheumatologists, and healthcare professionals to discuss advancements in bronchoscopic techniques, high-resolution imaging, and biomarker-driven diagnostics for ILD detection. Experts also explored new pharmacological treatments, including antifibrotic drugs and biologics, which are shaping ILD management in India.

The event featured international and national medical professionals, including Dr. Ganesh Raghu, Dr. Nishant Gupta, and Dr. Kalpalatha Guntupalli, among others. The Apollo Hospitals’ organizing committee, led by Dr. Sowmya Parimi and Dr. Vijay Kumar Chennamsetty, successfully conducted the conference, which covered AI-driven diagnostics, cryobiopsy for tissue acquisition, pulmonary rehabilitation, lung transplantation, and remote monitoring for ILD patients.

Apollo Hospitals’ CEO, Mr. V Tejesvi Rao, emphasized the organization’s commitment to integrating cutting-edge technology in respiratory care, stating that AI-driven imaging and biomarker-based diagnostics are transforming ILD detection, enabling earlier and more precise diagnoses. Dr. Ravindra Babu, Director Medical Services, Telangana Region, Apollo Hospitals, added that chronic respiratory diseases, including ILD, account for more than 12% of all deaths in India, and accurate diagnosis and tailored treatment plans are crucial.

ASPIRE 2025 served as a knowledge-sharing platform for specialists to advance data-driven ILD diagnosis and targeted therapeutic interventions. Apollo Hospitals’ commitment to pioneering evidence-based and technology-driven respiratory care marked an important step in improving ILD management across India. The hospital group’s goal is to bring cutting-edge technologies, equipment, and treatment protocols to ensure patients receive the best care available. With over 10,000 beds across 73 hospitals, 6,000 pharmacies, and 2,000 clinics and diagnostic centers, Apollo Hospitals is India’s largest integrated healthcare platform.

The STAT-2025 Conference on Stroke Thrombolysis and Thrombectomy was held at The Hotel Westin Mindspace in Hyderabad, India, bringing together leading international and national experts to discuss cutting-edge advances in acute stroke management, innovative imaging techniques, and critical procedural strategies. The conference aimed to facilitate the exchange of revolutionary ideas, techniques, and experiences among global leaders to transform stroke care.

Renowned international medical experts shared insights on advanced imaging, novel therapies, and groundbreaking thrombectomy procedures. Keynote speakers highlighted the importance of timely intervention in stroke management, early prediction techniques, and the need for tailored approaches in patient care. The conference also featured discussions on stroke epidemiology, including the changing demographics of stroke in India and the role of prehospital care in improving patient outcomes.

The conference also touched on imaging, introducing participants to essential parenchymal and vascular imaging methodologies, as well as advanced imaging techniques, including CT/MRI perfusion and artificial intelligence-driven algorithms. A session on thrombolysis and beyond explored the potential of novel therapeutic agents in treating acute stroke patients.

The second day of the conference focused on practical workshops, including hands-on training on mechanical thrombectomy and optimal use of thrombectomy devices. The sessions covered stroke triage systems, essential stroke scales, and rapid hospital-based evaluation methods. Interactive sessions, such as “How I Do It?” and “Perioperative Management,” provided practical insights into tailored approaches for thrombectomy and patient care.

The conference also tackled emerging challenges in stroke care, including distal medium vessel occlusions, interventions for basilar artery occlusions, and thrombectomy beyond the standard 24-hour treatment window. The-event brought together over 650 delegates from around the world, highlighting the global nature of collaborative stroke care advancements.

Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, emphasized the importance of innovation in stroke care, stating, “Innovation in stroke care demands courage, clinical judgment, and rigorous research. We are seeing therapies evolve rapidly, often challenging traditional guidelines. At Apollo Hospitals, we remain deeply invested in not just following established paths, but also forging new ones – guided by evidence, compassion, and clinical excellence.”